CAMBRIDGE, MA USA -- PHARMA UPDATE NEWS SERVICE™ -- JULY 5, 2007: The Third FDA Regulatory and Compliance Symposium, www.FDASymposium.com, August 22 - 24, 2007, in Cambridge, MA announced today that it will feature an Innovative Compliance Strategies Track.

THE VENUES AT HARVARD

Classes Held: Harvard University's Annenberg Hall, Lowell Hall, Science Center and the Harvard Faculty Club Symposium Hotel: The Charles Hotel

KEYNOTE SPEAKERS

Jerry Avorn, MD Professor of Medicine, Harvard Medical School, Chief, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Author, Powerful Medicines and The Benefits, Risks, and Costs of Prescription Drugs, Boston, MA Lester Crawford, DVM, PhD Senior Counsel, Policy Directions, Inc., Former Commissioner, FDA, Washington, DC Scott Gottlieb, MD Resident Fellow, American Enterprise Institute, Former Commissioner for Medical and Scientific Affairs, FDA, Washington, DC Sonali Gunawardhana, JD Regulatory Counsel, Center for Devices and Radiological Health, FDA, Rockville, MD Joseph Mahady President, Global Business, Wyeth Pharmaceuticals, Collegeville, PA Daniel Meron, Esq. General Counsel, Department of Health and Human Services, Former Principal Deputy Assistant Attorney General, Civil Division, United States Department of Justice, Washington, DC Jon F. Merz, MBA, JD, PhD Associate Professor, Associate Chair for Faculty Affairs, Department of Medical Ethics, University of Pennsylvania School of Medicine, Philadelphia, PA Arthur Miller, Esq. Bruce Bromley Professor of Law, Harvard Law School, Cambridge, MA Wayne Pines President, FDA Alliance, President, Regulatory Services and Healthcare, APCO Worldwide, Former Associate Commissioner for Public Affairs, FDA, Washington, DC Lucy Rose, MBA President, Lucy Rose and Associates, LLC; Former Director of the Office of Training and Communications and DDMAC, CDER, FDA David Rothman, PhD Bernard Schoenberg Professor of Social Medicine, Director of the Center for the Study of Society and Medicine, Columbia College of Physicians and Surgeons, Professor of History, Columbia University, New York, NY James G. Sheehan, Esq. New York State Medicaid, Inspector General, Former Associate United States Attorney, U.S. Attorney's Office for the Eastern District of Pennsylvania, Albany, NY Tom Stossel, MD Department of Medicine, Harvard Medical School, Co-Director, Division of Hematology, Brigham and Women's Hospital, Boston, MA Daniel Troy, Esq. Partner, Sidley Austin Brown & Wood, Former Chief Counsel, Office of the General Counsel, FDA, Washington, DC Marc Wilenzick, Esq. Assistant General Counsel, Pfizer, New York, NY Helen Winkle Director, Office of Pharmaceutical Science, Center for Drug Evaluation and Research, FDA Susan Wood, PhD Research Professor, School of Public Health and Health Services, George Washington University, Former Assistant Commissioner for Women's Health, and Director of the Office of Women's Health, FDA, Washington, DC

SPONSORED BY